Cronos Group Inc. (CRON)
USD 1.62
(-3.57%)
USD 1.62
(-3.57%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 30.33 Million USD | -19.22% |
| 2022 | 37.55 Million USD | 14.5% |
| 2021 | 32.8 Million USD | -25.45% |
| 2020 | 44 Million USD | 15.66% |
| 2019 | 38.04 Million CAD | 150.83% |
| 2018 | 15.16 Million CAD | 57.13% |
| 2017 | 9.65 Million CAD | 250.34% |
| 2016 | 2.75 Million CAD | 0.0% |
| 2015 | - CAD | -100.0% |
| 2014 | 17.22 Thousand CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 29.17 Million USD | -4.66% |
| 2024 Q1 | 30.6 Million USD | 0.88% |
| 2023 Q4 | 30.33 Million USD | -15.37% |
| 2023 FY | 30.33 Million USD | -19.22% |
| 2023 Q1 | 44.26 Million USD | 17.86% |
| 2023 Q2 | 45.19 Million USD | 2.08% |
| 2023 Q3 | 35.84 Million USD | -20.67% |
| 2022 Q2 | 39.84 Million USD | 7.52% |
| 2022 Q3 | 34.09 Million USD | -14.43% |
| 2022 Q1 | 37.05 Million USD | 12.96% |
| 2022 FY | 37.55 Million USD | 14.5% |
| 2022 Q4 | 37.55 Million USD | 10.16% |
| 2021 Q1 | 46.43 Million USD | 5.53% |
| 2021 Q4 | 32.8 Million USD | 3.25% |
| 2021 Q3 | 31.76 Million USD | -10.77% |
| 2021 FY | 32.8 Million USD | -25.45% |
| 2021 Q2 | 35.6 Million USD | -23.33% |
| 2020 Q1 | 43.11 Million USD | 13.34% |
| 2020 Q2 | 53.21 Million USD | 23.42% |
| 2020 Q4 | 44 Million USD | -21.93% |
| 2020 FY | 44 Million USD | 15.66% |
| 2020 Q3 | 56.35 Million USD | 5.91% |
| 2019 Q2 | 39.38 Million CAD | 43.44% |
| 2019 Q4 | 38.04 Million CAD | -8.38% |
| 2019 Q3 | 41.52 Million CAD | 5.44% |
| 2019 FY | 38.04 Million CAD | 150.83% |
| 2019 Q1 | 27.45 Million CAD | 81.01% |
| 2018 Q1 | 10.45 Million CAD | 8.33% |
| 2018 Q3 | 16.02 Million CAD | 9.59% |
| 2018 Q4 | 15.16 Million CAD | -5.36% |
| 2018 FY | 15.16 Million CAD | 57.13% |
| 2018 Q2 | 14.62 Million CAD | 39.85% |
| 2017 Q3 | 6.13 Million CAD | 45.11% |
| 2017 Q4 | 9.65 Million CAD | 57.35% |
| 2017 FY | 9.65 Million CAD | 250.34% |
| 2017 Q2 | 4.22 Million CAD | 12.71% |
| 2017 Q1 | 3.75 Million CAD | 36.13% |
| 2016 Q2 | 35.52 Thousand CAD | 0.0% |
| 2016 FY | 2.75 Million CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | 2.75 Million CAD | 49.71% |
| 2016 Q3 | 1.84 Million CAD | 5079.86% |
| 2015 Q2 | 16.11 Thousand CAD | 2.14% |
| 2015 FY | - CAD | -100.0% |
| 2015 Q3 | 14.89 Thousand CAD | -7.54% |
| 2015 Q4 | - CAD | -100.0% |
| 2015 Q1 | 15.77 Thousand CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 FY | 17.22 Thousand CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Journey Medical Corporation | 10.2 Million USD | -197.266% |
| ANI Pharmaceuticals, Inc. | 111.19 Million USD | 72.716% |
| Aquestive Therapeutics, Inc. | 6.76 Million USD | -348.205% |
| Pacira BioSciences, Inc. | 104.35 Million USD | 70.927% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -429.037% |
| Sunshine Biopharma, Inc. | 5.73 Million USD | -429.037% |
| SCYNEXIS, Inc. | - USD | -Infinity% |
| Safety Shot Inc | 1.86 Million USD | -1522.712% |
| Alpha Teknova, Inc. | 11.59 Million USD | -161.678% |
| Collegium Pharmaceutical, Inc. | 32.33 Million USD | 6.164% |
| Bright Green Corporation | - USD | -Infinity% |
| Dynavax Technologies Corporation | 53.29 Million USD | 43.068% |
| Esperion Therapeutics, Inc. | 65.62 Million USD | 53.768% |
| Cosmos Health Inc. | 4.78 Million USD | -533.507% |
| PainReform Ltd. | - USD | -Infinity% |
| China SXT Pharmaceuticals, Inc. | 809.75 Thousand USD | -3646.677% |
| Embecta Corp. | 152.1 Million USD | 80.053% |
| Intra-Cellular Therapies, Inc. | 11.64 Million USD | -160.487% |
| Procaps Group, S.A. | 96.83 Million USD | 68.669% |
| Theratechnologies Inc. | 6.06 Million USD | -400.148% |
| Harrow Health, Inc. | 10.86 Million USD | -179.184% |
| Sonoma Pharmaceuticals, Inc. | 2.71 Million USD | -1015.814% |
| Biofrontera Inc. | 10.9 Million USD | -178.135% |
| DURECT Corporation | 2.21 Million USD | -1267.237% |
| Supernus Pharmaceuticals, Inc. | 77.4 Million USD | 60.806% |
| OptiNose, Inc. | 8.05 Million USD | -276.788% |
| Ironwood Pharmaceuticals, Inc. | 1.00 USD | -3033897700.0% |
| Kala Pharmaceuticals, Inc. | - USD | -Infinity% |
| RedHill Biopharma Ltd. | 5.69 Million USD | -432.353% |
| Organogenesis Holdings Inc. | 28.25 Million USD | -7.383% |
| Guardion Health Sciences, Inc. | 2.67 Million USD | -1033.273% |
| Cumberland Pharmaceuticals Inc. | 4.6 Million USD | -558.203% |
| Radius Health, Inc. | 278.64 Million USD | 89.112% |
| Universe Pharmaceuticals INC | 3.34 Million USD | -807.465% |
| ProPhase Labs, Inc. | 3.84 Million USD | -689.872% |
| Phibro Animal Health Corporation | 265.91 Million USD | 88.591% |
| Procaps Group S.A. | 96.83 Million USD | 68.669% |
| Alvotech | 74.43 Million USD | 59.24% |
| TherapeuticsMD, Inc. | - USD | -Infinity% |
| Viatris Inc. | 3.46 Billion USD | 99.126% |
| Rockwell Medical, Inc. | 5.87 Million USD | -416.76% |
| Aytu BioPharma, Inc. | 12.63 Million USD | -140.157% |
| SIGA Technologies, Inc. | 64.21 Million USD | 52.757% |
| Tilray Brands, Inc. | 252.08 Million USD | 87.965% |
| Lifecore Biomedical, Inc. | 39.97 Million USD | 24.113% |
| Shineco, Inc. | 1.58 Million USD | -1809.884% |
| PetIQ, Inc. | 159.3 Million USD | 80.956% |
| Regencell Bioscience Holdings Limited | -152.77 Thousand USD | 19958.211% |
| Incannex Healthcare Limited | -10.01 Million USD | 402.935% |
| Neurocrine Biosciences, Inc. | 38.3 Million USD | 20.786% |
| Alimera Sciences, Inc. | 1.87 Million USD | -1514.634% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 37.68 Million USD | 19.495% |
| Shuttle Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Petros Pharmaceuticals, Inc. | 1.61 Million USD | -1783.951% |
| Clever Leaves Holdings Inc. | 4.48 Million USD | -576.756% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -11827.949% |
| Avadel Pharmaceuticals plc | 10.38 Million USD | -192.283% |
| Hempacco Co., Inc. | 2.54 Million USD | -1093.213% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 74.43 Million USD | 59.24% |
| Eagle Pharmaceuticals, Inc. | 47.79 Million USD | 36.521% |
| Lantheus Holdings, Inc. | 64.02 Million USD | 52.617% |
| Currenc Group, Inc. | 732.91 Thousand USD | -4039.517% |
| Kamada Ltd. | 87.74 Million USD | 65.424% |
| Indivior PLC | 141.79 Million USD | 78.604% |
| Evoke Pharma, Inc. | 481.84 Thousand USD | -6196.484% |
| Flora Growth Corp. | 8.5 Million USD | -256.594% |
| Cyclo Therapeutics, Inc. | 254.35 Thousand USD | -11827.949% |
| Evolus, Inc. | 10.99 Million USD | -175.859% |
| HUTCHMED (China) Limited | 50.25 Million USD | 39.634% |
| Amphastar Pharmaceuticals, Inc. | 105.83 Million USD | 71.333% |
| Akanda Corp. | 1.28 Million USD | -2257.535% |